Erbitux Oversight Alliance 607 Elmira Road PNB 331 Vacaville, CA[removed]5886 January 29, 2002 The Honorable W.J. Tauzin, Chairman, House Committee on Energy and Commerce

First Page		Document Content
Date: 2009-05-28 08:43:24 Research Pharmaceutical industry Clinical research Eli Lilly and Company ImClone Systems Cetuximab Clinical trial New Drug Application Pharmaceutical sciences Pharmacology Food and Drug Administration		Erbitux Oversight Alliance 607 Elmira Road PNB 331 Vacaville, CA[removed]5886 January 29, 2002 The Honorable W.J. Tauzin, Chairman, House Committee on Energy and Commerce Add to Reading List Source URL: www.canceractionnow.org Download Document from Source Website File Size: 20,29 KB Share Document on Facebook

	PROUD PROUD Participant Involvement meeting: Trial Design Date: Tuesday 9th September – 20.00 Venue: MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, Holborn, WC2B 6NH Contact person: Mitzy Gaf DocID: 1vq4y - View Document
	Clinical Review & Education JAMA \| Special Communication Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols DocID: 1vmrb - View Document
	For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte DocID: 1vkmw - View Document
	DEPARTMENT OF HEALTH DRUG OFFICE DRUG REGISTRATION AND IMPORT/EXPORT CONTROL DIVISION Guidance Notes on the Application for Certificate for Clinical Trial/Medicinal Test Background DocID: 1vkj3 - View Document
	CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and DocID: 1vbDv - View Document